KarinCA Tuesday, 06/26/18 05:05:53 PM Re: hedgeclipper post# 37 Post # of 46 It's too early to know this since no clinical trials have been started yet. I've learned the hard way that entering biotech too early is usually a mistake. https://clinicaltrials.gov/ct2/results?cond=&term=CohBar+Inc&cntry=&state=&city=&dist=&Search=Search Please correct me if I'm wrong and they've at least done a phase I safety trial in another country. I've not had time to do the research and it appears you may have done so. Thanks... In Reply to 'hedgeclipper' IMO a buying opportunity. All the fundamentals still there for CohBar to be the next (and best) NASH play. To follow KarinCA, click here then click "Follow This Member" under my photo. Be kinder than necessary, for everyone you meet is fighting some kind of battle.